Xiaolin Zhong

449 total citations
47 papers, 299 citations indexed

About

Xiaolin Zhong is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Xiaolin Zhong has authored 47 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Surgery and 10 papers in Immunology. Recurrent topics in Xiaolin Zhong's work include Liver Disease Diagnosis and Treatment (7 papers), Immune cells in cancer (4 papers) and Pancreatitis Pathology and Treatment (3 papers). Xiaolin Zhong is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Immune cells in cancer (4 papers) and Pancreatitis Pathology and Treatment (3 papers). Xiaolin Zhong collaborates with scholars based in China, United States and Thailand. Xiaolin Zhong's co-authors include Juyi Wan, Muhan Lü, Menghao Huang, Yang Zhang, Hyeong-Geug Kim, Romil Saxena, Robert F. Schwabe, Suthat Liangpunsakul, X. Charlie Dong and Wenjie Cai and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Medicine.

In The Last Decade

Xiaolin Zhong

36 papers receiving 294 citations

Peers

Xiaolin Zhong
Zemou Yu China
Yajie Yu China
Parth Patel United States
Tailong Yi China
Lan Xu China
Wenzhao Liang China
Sophie Tan France
Anna P. Koh United States
Daniela Lambertz Germany
Tiantian Zhao China
Zemou Yu China
Xiaolin Zhong
Citations per year, relative to Xiaolin Zhong Xiaolin Zhong (= 1×) peers Zemou Yu

Countries citing papers authored by Xiaolin Zhong

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Zhong more than expected).

Fields of papers citing papers by Xiaolin Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Zhong. The network helps show where Xiaolin Zhong may publish in the future.

Co-authorship network of co-authors of Xiaolin Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Zhong. A scholar is included among the top collaborators of Xiaolin Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Zhong. Xiaolin Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Zheng, Jie, Zhiping Lin, Xiaolin Zhong, & Jianghua Liu. (2025). The relationship between programmed cell death and vascular calcification. Frontiers in Cardiovascular Medicine. 12. 1549857–1549857.
5.
Sang, Xinting, Lai Jiang, Shengke Zhang, et al.. (2025). Deciphering the role of acetylation-related gene NAT10 in colon cancer progression and immune evasion: implications for overcoming drug resistance. Discover Oncology. 16(1). 774–774. 2 indexed citations
6.
Zhang, Zongquan, Guan Wang, Zhuo Zhang, et al.. (2025). Locally administered liposomal drug depot enhances rheumatoid arthritis treatment by inhibiting inflammation and promoting cartilage repair. Journal of Nanobiotechnology. 23(1). 69–69. 6 indexed citations
7.
Tang, Xiaowei, Jiao Jiang, Shu Huang, et al.. (2024). Long-term trends in cancer incidence and mortality among U.S. children and adolescents: a SEER database analysis from 1975 to 2018. Frontiers in Pediatrics. 12. 1357093–1357093. 5 indexed citations
8.
Tang, Xiaowei, Yuan Chen, Shu Huang, et al.. (2024). Acute Pancreatitis in Pregnancy: A Propensity Score Matching Analysis and Dynamic Nomogram for Risk Assessment. Digestive Diseases and Sciences. 69(6). 2235–2246.
9.
Li, Yantong, et al.. (2024). Bibliometric analysis of the correlation between H. pylori and inflammatory bowel disease. JGH Open. 8(8). e70014–e70014. 1 indexed citations
10.
Luo, Miaw-Chyi, Wei Zhang, Juan Yang, et al.. (2024). CD83 mediates the inhibitory effect of the S1PR1 agonist CYM5442 on LPS-induced M1 polarization of macrophages through the ERK-STAT-1 signaling pathway. International Immunopharmacology. 143(Pt 3). 113526–113526.
11.
Zhang, Mingrui, Yuda Zhu, Jun‐Feng Kou, et al.. (2024). A near-infrared II fluorescent dye based on oxanthracene: Real-time imaging of drug-induced acute liver injury and photothermal therapy for tumor. Chinese Chemical Letters. 36(10). 110772–110772. 1 indexed citations
12.
Zhang, Jianhua, Fang Wang, Li Mao, et al.. (2024). Asiaticoside alleviates lipopolysaccharide-induced acute lung injury by blocking Sema4D/CD72 and inhibiting mitochondrial dysfunction in RAW264.7 cell and mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(10). 7573–7587. 4 indexed citations
13.
Tang, Xiaowei, Bei Luo, Shu Huang, et al.. (2023). Gender differences of authors of major Hepatology society guidelines during the past 15 years. Liver International. 43(7). 1407–1416.
14.
Tang, Hongmei, Yun Zhang, Ziling Zeng, et al.. (2023). Astaxanthin attenuated cigarette smoke extract-induced apoptosis via decreasing oxidative DNA damage in airway epithelium. Biomedicine & Pharmacotherapy. 167. 115471–115471. 7 indexed citations
15.
Tang, Xiaowei, Bei Luo, Shu Huang, et al.. (2023). FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma. European journal of medical research. 28(1). 419–419. 5 indexed citations
16.
Tang, Xiaowei, Ping Wang, Jiao Jiang, et al.. (2023). Global burden of early-onset colorectal cancer among people aged 40–49 years from 1990 to 2019 and predictions to 2030. Journal of Cancer Research and Clinical Oncology. 149(18). 16537–16550. 9 indexed citations
17.
Fang, Huan, et al.. (2023). Role of sestrins in metabolic and aging-related diseases. Biogerontology. 25(1). 9–22. 5 indexed citations
18.
Du, Fei, Jian Wang, Suwit Duangmano, et al.. (2023). The role of mitochondria in the resistance of melanoma to PD-1 inhibitors. Journal of Translational Medicine. 21(1). 345–345. 25 indexed citations
19.
20.
Zhong, Xiaolin, et al.. (2018). Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression. Biomedicine & Pharmacotherapy. 107. 382–389. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zemou Yu Breakdown of academic impact, for papers by Yajie Yu Breakdown of academic impact, for papers by Parth Patel Breakdown of academic impact, for papers by Tailong Yi Breakdown of academic impact, for papers by Lan Xu Breakdown of academic impact, for papers by Wenzhao Liang Breakdown of academic impact, for papers by Sophie Tan Breakdown of academic impact, for papers by Anna P. Koh Breakdown of academic impact, for papers by Daniela Lambertz Breakdown of academic impact, for papers by Tiantian Zhao
Rankless by CCL
2026